Evidence map›Paper›PMID 22328576›Full record

ArticleThe Journal of pharmacology and experimental therapeutics2012

Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.

Daniel F Manvich, Heather L Kimmel, Leonard L Howell

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of pharmacology and experimental therapeutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03192995 (Treatment With Lorcaserin for Cocaine Use), which is not on this map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03192995 phase2terminatednot on this mapstarted 2018, after this paper: background citation

Treatment With Lorcaserin for Cocaine Use: The TLC Study

TypeinterventionalSponsorGlenn-Milo SantosRan2018 to 2020Enrolled22ConditionsCocaine Use DisorderArmslorcaserin, Placebo Oral Tablet, Substance use counseling, ACASI, Cocaine metabolites
3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 65 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Serotonin 5-HTFrontiers in neuroscience · 2025
    Article
  4. Article
  5. Evaluation of the 5-HTPharmacological reports : PR · 2023
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Effects of long-term high-fat food or methamphetamine intake and serotonin 2C receptors on reversal learning in female rhesus macaques.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Behavioral mechanisms underlying the maternal disruptive effect of serotonin 5-HTJournal of neural transmission (Vienna, Austria : 1996) · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Daniel F ManvichYerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Heather L Kimmel
Leonard L Howell
Emory University · US

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI RENGARAJAN, JYOTHI · 1985 to 2011
$114.0M
COCAINE USE AND MONOAMINE FUNCTION IN NONHUMAN PRIMATESR01DA012514 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2000 to 2014
$5.5M
The mt-DNA mutator mouseZ01DA000517 · NIDA · NATIONAL INSTITUTE ON DRUG ABUSE · PI HOFFER, BARRY J · 2007 to 2008
$1.1M
Neuropharmacology of Cocaine in Nonhuman PrimatesK02DA000517 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2001 to 2010
$1.1M
Neuropharmacology of Abused Stimulants in Nonhuman PrimatesK05DA031246 · NIDA · EMORY UNIVERSITY · PI HOWELL, LEONARD L · 2012 to 2016
$619k
Effects of mGluR2/3 Activation on Cue-Induced Cocaine Relapse in Squirrel MonkeysF31DA026262 · NIDA · EMORY UNIVERSITY · PI MANVICH, DANIEL F. · 2009 to 2010
$59k
Intramural NIH HHS Z01 DA000517NCRR NIH HHS P51 RR000165NCRR NIH HHS RR00165NIDA NIH HHS DA12514NIDA NIH HHS F31 DA026262NIDA NIH HHS F31-DA026262NIDA NIH HHS F31DA026262NIDA NIH HHS K02 DA000517NIDA NIH HHS K05 DA031246NIDA NIH HHS R01 DA012514
6 · The paper itself

Abstract

Accumulating evidence indicates that the serotonin system modulates the behavioral and neurochemical effects of cocaine, but the receptor subtypes mediating these effects remain unknown. Recent studies have demonstrated that pharmacological activation of the serotonin 2C receptor (5-HT(2C)R) attenuates the behavioral and neurochemical effects of cocaine in rodents, but such compounds have not been systematically evaluated in nonhuman primates. The present experiments sought to determine the impact of pretreatment with the preferential 5-HT(2C)R agonist m-chlorophenylpiperazine (mCPP) and the selective 5-HT(2C)R agonist Ro 60-0175 [(α-S)-6-chloro-5-fluoro-α-methyl-1H-indole-1-ethanamine fumarate] on the behavioral and neurochemical effects of cocaine in squirrel monkeys. In subjects trained to lever-press according to a 300-s fixed-interval schedule of stimulus termination, pretreatment with either 5-HT(2C)R agonist dose-dependently and insurmountably attenuated the behavioral stimulant effects of cocaine. In subjects trained to self-administer cocaine, both compounds dose-dependently and insurmountably attenuated cocaine-induced reinstatement of previously extinguished responding in an antagonist-reversible manner, and the selective agonist Ro 60-0175 also attenuated the reinforcing effects of cocaine during ongoing cocaine self-administration. It is noteworthy that the selective agonist Ro 60-0175 exhibited behavioral specificity because it did not significantly alter nondrug-maintained responding. Finally, in vivo microdialysis studies revealed that pretreatment with Ro 60-0175 caused a reduction of cocaine-induced dopamine increases within the nucleus accumbens, but not the caudate nucleus. These results suggest that 5-HT(2C)R agonists functionally antagonize the behavioral effects of cocaine in nonhuman primates, possibly via a selective modulation of cocaine-induced dopamine increases within the mesolimbic dopamine system and may therefore represent a novel class of pharmacotherapeutics for the treatment of cocaine abuse.

Indexed as

AnimalsBehavior, AnimalCaudate NucleusCocaineDopamineDrug InteractionsEthylaminesIndolesMaleMicrodialysisNucleus AccumbensPiperazinesReceptor, Serotonin, 5-HT2CSaimiriSelf AdministrationSerotonin 5-HT2 Receptor Agonists1-(3-chlorophenyl)piperazineCocaineDopamineEthylaminesIndolesPiperazinesReceptor, Serotonin, 5-HT2CRo 60-0175Serotonin 5-HT2 Receptor Agonists

Identifiers

PMID22328576
PMCPMC3336818
OpenAlexW2142929272

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.